Literature DB >> 20852131

Deletion-based mechanisms of Notch1 activation in T-ALL: key roles for RAG recombinase and a conserved internal translational start site in Notch1.

Todd D Ashworth1, Warren S Pear, Mark Y Chiang, Stephen C Blacklow, Jérôme Mastio, Lanwei Xu, Michelle Kelliher, Philippe Kastner, Susan Chan, Jon C Aster.   

Abstract

Point mutations that trigger ligand-independent proteolysis of the Notch1 ectodomain occur frequently in human T-cell acute lymphoblastic leukemia (T-ALL) but are rare in murine T-ALL, suggesting that other mechanisms account for Notch1 activation in murine tumors. Here we show that most murine T-ALLs harbor Notch1 deletions that fall into 2 types, both leading to ligand-independent Notch1 activation. Type 1 deletions remove exon 1 and the proximal promoter, appear to be RAG-mediated, and are associated with mRNA transcripts that initiate from 3' regions of Notch1. In line with the RAG dependency of these rearrangements, RAG2 binds to the 5' end of Notch1 in normal thymocytes near the deletion breakpoints. Type 2 deletions remove sequences between exon 1 and exons 26 to 28 of Notch1, appear to be RAG-independent, and are associated with transcripts in which exon 1 is spliced out of frame to 3' Notch1 exons. Translation of both types of transcripts initiates at a conserved methionine residue, M1727, which lies within the Notch1 transmembrane domain. Polypeptides initiating at M1727 insert into membranes and are subject to constitutive cleavage by γ-secretase. Thus, like human T-ALL, murine T-ALL is often associated with acquired mutations that cause ligand-independent Notch1 activation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20852131      PMCID: PMC3031398          DOI: 10.1182/blood-2010-05-286328

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  44 in total

1.  Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations.

Authors:  Chengming Zhu; Kevin D Mills; David O Ferguson; Charles Lee; John Manis; James Fleming; Yijie Gao; Cynthia C Morton; Frederick W Alt
Journal:  Cell       Date:  2002-06-28       Impact factor: 41.582

2.  Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.

Authors:  Andrew P Weng; Adolfo A Ferrando; Woojoong Lee; John P Morris; Lewis B Silverman; Cheryll Sanchez-Irizarry; Stephen C Blacklow; A Thomas Look; Jon C Aster
Journal:  Science       Date:  2004-10-08       Impact factor: 47.728

3.  Signal transduction by activated mNotch: importance of proteolytic processing and its regulation by the extracellular domain.

Authors:  R Kopan; E H Schroeter; H Weintraub; J S Nye
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

4.  Frequent provirus insertional mutagenesis of Notch1 in thymomas of MMTVD/myc transgenic mice suggests a collaboration of c-myc and Notch1 for oncogenesis.

Authors:  L Girard; Z Hanna; N Beaulieu; C D Hoemann; C Simard; C A Kozak; P Jolicoeur
Journal:  Genes Dev       Date:  1996-08-01       Impact factor: 11.361

5.  Spectrum of Znfn1a1 (Ikaros) inactivation and its association with loss of heterozygosity in radiogenic T-cell lymphomas in susceptible B6C3F1 mice.

Authors:  Shizuko Kakinuma; Mayumi Nishimura; Syun-Ichi Sasanuma; Kazuei Mita; Gen Suzuki; Yoshimoto Katsura; Toshihiko Sado; Yoshiya Shimada
Journal:  Radiat Res       Date:  2002-03       Impact factor: 2.841

6.  Perturbation of Ikaros isoform selection by MLV integration is a cooperative event in Notch(IC)-induced T cell leukemogenesis.

Authors:  Levi J Beverly; Anthony J Capobianco
Journal:  Cancer Cell       Date:  2003-06       Impact factor: 31.743

7.  Transcription elongation factors repress transcription initiation from cryptic sites.

Authors:  Craig D Kaplan; Lisa Laprade; Fred Winston
Journal:  Science       Date:  2003-08-22       Impact factor: 47.728

8.  Thymopoiesis independent of common lymphoid progenitors.

Authors:  David Allman; Arivazhagan Sambandam; Sungjune Kim; Juli P Miller; Antonio Pagan; David Well; Anita Meraz; Avinash Bhandoola
Journal:  Nat Immunol       Date:  2003-01-06       Impact factor: 25.606

9.  TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms.

Authors:  L W Ellisen; J Bird; D C West; A L Soreng; T C Reynolds; S D Smith; J Sklar
Journal:  Cell       Date:  1991-08-23       Impact factor: 41.582

10.  Radiation-induced deletions in the 5' end region of Notch1 lead to the formation of truncated proteins and are involved in the development of mouse thymic lymphomas.

Authors:  Hideo Tsuji; Hiroko Ishii-Ohba; Hideki Ukai; Takanori Katsube; Toshiaki Ogiu
Journal:  Carcinogenesis       Date:  2003-05-09       Impact factor: 4.944

View more
  61 in total

1.  An activating intragenic deletion in NOTCH1 in human T-ALL.

Authors:  J Erika Haydu; Kim De Keersmaecker; Mary Kaye Duff; Elisabeth Paietta; Janis Racevskis; Peter H Wiernik; Jacob M Rowe; Adolfo Ferrando
Journal:  Blood       Date:  2012-04-17       Impact factor: 22.113

2.  FGFR1OP2-FGFR1 induced myeloid leukemia and T-cell lymphoma in a mouse model.

Authors:  Haiyan Qin; Qing Wu; John K Cowell; Mingqiang Ren
Journal:  Haematologica       Date:  2015-11-20       Impact factor: 9.941

Review 3.  The molecular pathogenesis of chronic lymphocytic leukaemia.

Authors:  Giulia Fabbri; Riccardo Dalla-Favera
Journal:  Nat Rev Cancer       Date:  2016-03       Impact factor: 60.716

Review 4.  Critical roles of NOTCH1 in acute T-cell lymphoblastic leukemia.

Authors:  Hudan Liu; Mark Y Chiang; Warren S Pear
Journal:  Int J Hematol       Date:  2011-08-05       Impact factor: 2.490

5.  Cutting Edge: Codeletion of the Ras GTPase-Activating Proteins (RasGAPs) Neurofibromin 1 and p120 RasGAP in T Cells Results in the Development of T Cell Acute Lymphoblastic Leukemia.

Authors:  Beth A Lubeck; Philip E Lapinski; Jennifer A Oliver; Olga Ksionda; Luis F Parada; Yuan Zhu; Ivan Maillard; Mark Chiang; Jeroen Roose; Philip D King
Journal:  J Immunol       Date:  2015-05-22       Impact factor: 5.422

6.  Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia.

Authors:  Alejandro Gutierrez; Li Pan; Richard W J Groen; Frederic Baleydier; Alex Kentsis; Jason Marineau; Ruta Grebliunaite; Elena Kozakewich; Casie Reed; Francoise Pflumio; Sandrine Poglio; Benjamin Uzan; Paul Clemons; Lynn VerPlank; Frank An; Jason Burbank; Stephanie Norton; Nicola Tolliday; Hanno Steen; Andrew P Weng; Huipin Yuan; James E Bradner; Constantine Mitsiades; A Thomas Look; Jon C Aster
Journal:  J Clin Invest       Date:  2014-01-09       Impact factor: 14.808

7.  Common nonmutational NOTCH1 activation in chronic lymphocytic leukemia.

Authors:  Giulia Fabbri; Antony B Holmes; Mara Viganotti; Claudio Scuoppo; Laura Belver; Daniel Herranz; Xiao-Jie Yan; Yasmine Kieso; Davide Rossi; Gianluca Gaidano; Nicholas Chiorazzi; Adolfo A Ferrando; Riccardo Dalla-Favera
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-17       Impact factor: 11.205

8.  Genome-wide analysis reveals conserved and divergent features of Notch1/RBPJ binding in human and murine T-lymphoblastic leukemia cells.

Authors:  Hongfang Wang; James Zou; Bo Zhao; Eric Johannsen; Todd Ashworth; Hoifung Wong; Warren S Pear; Jonathan Schug; Stephen C Blacklow; Kelly L Arnett; Bradley E Bernstein; Elliott Kieff; Jon C Aster
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-07       Impact factor: 11.205

9.  Complementary genomic screens identify SERCA as a therapeutic target in NOTCH1 mutated cancer.

Authors:  Giovanni Roti; Anne Carlton; Kenneth N Ross; Michele Markstein; Kostandin Pajcini; Angela H Su; Norbert Perrimon; Warren S Pear; Andrew L Kung; Stephen C Blacklow; Jon C Aster; Kimberly Stegmaier
Journal:  Cancer Cell       Date:  2013-02-21       Impact factor: 31.743

10.  Notch1 inhibition targets the leukemia-initiating cells in a Tal1/Lmo2 mouse model of T-ALL.

Authors:  Jessica Tatarek; Kathleen Cullion; Todd Ashworth; Rachel Gerstein; Jon C Aster; Michelle A Kelliher
Journal:  Blood       Date:  2011-06-13       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.